BackgroundA review of research priorities completed by WHO technical units was undertaken. Results of the mapping were recorded in a database that was used to generate analysis and compare research priorities and the different methodological approaches used in their development.MethodsA total of 116 documents were reviewed for this study. The documents were published between 2002 and 2017 by the technical programmes of WHO headquarters and deposited in the institutional repository, IRIS. Research priorities were extracted from documents into a standard template and mapped to a five-category research cycle type framework defined in the WHO Strategy on Research for Health covering research to describe the research problem, identifying the cause and risk factors, developing solutions and new interventions, understanding the barriers to implementation, and evaluation of the impact of response. Details of the research priority methods were recorded. A database with user interface was created using Microsoft Excel 2010.ResultsA total of 2145 research priorities were extracted from the 116 documents meeting the inclusion criteria. The priorities specifically address 73 diseases/health topics. The document types were 26% Report, 22% WHO Guideline, 26% Research Prioritisation publication and 11% Meeting Notes. The most widely reported method used to identify priorities was expert consultation. Expert consultation was used to identify 86% of the priorities categorised here, with 26% (561) reporting it as the sole method; 52% (1111) explicitly listed a literature review as contributing to the identification of priorities. When the 2145 priorities were categorised across the research cycle framework, the largest portion (43%) addressed implementation challenges. The database is published here under an open access licence.ConclusionComparing research priorities between diseases/health topics requires standardisation and the research cycle type framework is one approach that can be applied across all the health topics found in public health. There is great variation in the use of research priority-setting methodology at WHO Headquarters. Therefore, a standard reporting approach, linked to established good practice, should be an area for future development by the WHO Global Health R&D Observatory. The database reported here can also be used to quickly access and analyse the research priorities for a specific health topic or to compare across a range of health topics.Electronic supplementary materialThe online version of this article (10.1186/s12961-018-0391-0) contains supplementary material, which is available to authorized users.
With a few exceptions, prevailing data on return to work after coronary artery bypass surgery indicate no net gain in employment status for at least several years after the operation. Despite the improved surgical experience and advances in the medical management of postoperative patients, only limited employment benefits occur after surgery, and no gains in work rehabilitation over the past decade have been noted. Several characteristics--preoperative work status, nonwork income, occupation, relief of symptoms, age, perception of health, education and severity of disease--appear to be important for estimating the likelihood of employment after surgery. Other influences, such as attitudes of the family, employers and physicians, undoubtedly alter the probability of return to the work force, but are less well documented. Unless constructive approaches toward work rehabilitation are made, the possibility of return to gainful employment should not be considered an indication for or a necessary consequence of coronary artery bypass surgery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.